Skip to content

Population pharmacokinetic and pharmacodynamic modeling of propofol in underweight patients under general anesthesia

Population pharmacokinetic and pharmacodynamic modeling of propofol in underweight patients under general anesthesia

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
CRIS
Registry ID
KCT0001760
Enrollment
20
Registered
2016-01-07
Start date
2015-09-09
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : Patients received an initial intravenous bolus of propofol 2.0 mg/kg. Time to loss of consciousness (LOC) was determined every 5 s by the loss of response to verbal command. After

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. 20 yr < age <65 yr 2. BMI (body mass index) < 18.5 (kg/m2) 3. Hemoglobin > 9 g/dl 4. Patients who signed a written informed consent form

Exclusion criteria

Exclusion criteria: 1-1. Patients with severely impaired respiratory function or respiratory depression status 1-2. Patients with convulsive disorders, head injury, shock, a reduced level of consciousness of uncertain origin, intracranial lesions or increased intracranial pressure, or in patients with severe hepatic impairment 1-3. Patients who are concurrently taking other CNS depressants that may cause respiratory depression, hypotension, profound sedation or potentially result in coma 1-4. Clinically significant impairment of cardiovascular, respiratory and renal function 2. Patients with known hypersensitivity to intervention treatments (propofol) or to any of the excipients 3. Patients who are considered by the investigator to be unsuitable to participate in the study for any other reason not mentioned in the inclusion and exclusion criteria.

Design outcomes

Primary

MeasureTime frame
voluem of distribution, clearance

Secondary

MeasureTime frame
Area ynder the curve

Countries

Korea, Republic of

Contacts

Public ContactByungmoon Choi

Asan Medical Center

rios76@hanmail.net+82-2-3010-1704

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Mar 6, 2026